4.0 Article

Is there a role for differentiating therapy in non-APL AML?

期刊

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.beha.2010.09.014

关键词

acute myeloid leukemia; AML; differentiation; retinoids; PPAR ligands; cytokines; kinase inhibitors; histone deacetylase; methylation; CEBP

资金

  1. NCI NIH HHS [R01 CA026038-31, R01 CA026038, R01 CA026038-32, R01 CA026038-30A2] Funding Source: Medline

向作者/读者索取更多资源

Differentiation therapy with all-trans retinoic acid has been a very successful therapeutic strategy in acute promyelocytic leukemia (APL), but the value of differentiation therapy in acute myeloid leukemia (AML) remains to be determined. A number of current treatments, such as tyrosine kinase inhibitors, cytokines, and epigenetic agents, induce differentiation of leukemic cells to some extent, but differentiation is not the main goal of these treatments. Forcing expression of certain transcription factors, such as C/EBP, has also been useful in inducing differentiation in cell lines and in murine models, but an effective way to force expression of these genes in humans is yet to be discovered. (C) 2010 Published by Elsevier Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据